Cite
MLA Citation
Jonathan A Ledermann et al.. “Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.” Lancet oncology, vol. 17, no. 11, n.d., pp. 1579–1589. http://access.bl.uk/ark:/81055/vdc_100038840370.0x000024